Cision PR Newswire

Royal Marines field 2,000+ MPU5 radios, entering a new phase of large-scale operational deployment and collaboration with allied forces Wave Relay® MANET technology creates a global communications fabric, enabling the Royal Marines to dominate in contested environments NEW YORK, Oct. 28, 2025 /PRNewswire/ -- Persistent Systems, LLC ("Persistent"), a leader in mobile ad hoc network (MANET) technology, announced that the UK Royal Marines have now fully fielded over 2,000 MPU5 radio systems in support of their UK Commando Force (UKCF) transformation. This marks a significant step in the Royal Marines' move toward a more agile, technology-enabled expeditionary force.

Persistent Systems logo (PRNewsfoto/Persistent Systems, LLC)

11 new abstracts including MASH data to be presented at the 76th Annual AASLD The Liver Meeting®, 7-11 November Highlights include data from post-hoc analyses of the ESSENCE trial investigating the effects of Wegovy® (semaglutide 2.4 mg) in MASH in relation to the magnitude of weight loss and across diverse populations1,2 BAGSVÆRD, Denmark and PLAINSBORO, N.J., Oct. 28, 2025 /PRNewswire/ -- Novo Nordisk today announced plans to present 11 abstracts at the 76th Annual American Association for the Study of Liver Diseases (AASLD) congress, The Liver Meeting® 2025, from 7 to 11 November in Washington D.C., U.S. Highlights include clinical and real-world data investigating the clinical profile of Wegovy® (semaglutide 2.4 mg) in metabolic dysfunction-associated steatohepatitis (MASH) in relation to weight loss and across diverse patient populations. In addition to semaglutide 2.4 mg data, real-world data will be presented that evaluate the benefit of non-invasive tests (NITs).

Novo Nordisk, Inc.  (PRNewsFoto/Novo Nordisk)

NEW YORK, Oct. 28, 2025 /PRNewswire/ -- AEA Investors ("AEA" or the "Firm") is pleased to announce it has been named to Inc.'s 2025 Founder-Friendly Investors list, marking the third consecutive year AEA has been recognized for its commitment to supporting founder-led businesses. The annual list recognizes investment firms with strong track records of backing founder-led companies and helping them thrive. For more than five decades, AEA has partnered with the management teams of leading middle market companies to help accelerate growth and build enduring businesses. Through its …

UC Berkeley physicist and CERN collaborator brings decades of plasma and beam physics leadership to compact fusion pioneer TEL AVIV, Israel, Oct. 28, 2025 /PRNewswire/ -- nT-Tao, the compact fusion power company pioneering next-generation clean energy solutions, today announced that Jonathan S. Wurtele, Ph.D., has been appointed to its Advisory Board. Dr. Wurtele joins at a pivotal time for nT-Tao as the company advances its fusion research capabilities and accelerates toward commercialization. His deep expertise in plasma physics, accelerator theory, and non-linear dynamics will enhance the technical guidance and strategic perspective available to the company's leadership team.

DENVER, Oct. 28, 2025 /PRNewswire/ -- UnionHub, a leading fintech and insurtech platform transforming benefits and payment experiences for employers, associations, unions, TPAs, and insurance carriers, today announced its membership in the LIMRA Data Exchange Standards (LDEx™) committee. The partnership reinforces UnionHub's commitment to enhancing security, interoperability, and data integrity across the employee benefits landscape.

UnionHub logo (PRNewsfoto/UnionHub)

FORT LAUDERDALE, Fla., Oct. 28, 2025 /PRNewswire/ -- LPL announced today that Travis Serpas has joined the company as Vice President / Project Executive. Travis brings more than 22 years of experience in construction management and utility-scale solar. "Travis brings the leadership skills and experience to support our continued growth," said Mike Little, President of LPL Solar. "I've known Travis for over 20 years; he will make an immediate impact on our leadership and operational teams."

(PRNewsfoto/LPL Solar)

MIAMI, Oct. 28, 2025 /PRNewswire/ -- FlexAgain scored top in terms of customer satisfaction and efficacy in the joint supplements category in the 20,000 person survey. The survey is part of HLTH's annual consumer satisfaction survey that covers all elements the health supplements market. FlexAgain also scored 3rd in overall supplements. The joint supplement continues to go from strength to strength having previously had accolades such as best joint supplement from Discover, Athletics Weekly and other well-regarded publications. The FlexAgain CEO had the following to say "honestly, we're really proud of this one, of course all accolades are nice, but one that's voted for by the customers always carries a bit more weight. It shows we're doing things right."

FlexAgain Logo (PRNewsfoto/FlexAgain)

The new space expands Lupin's footprint in New Jersey, underscoring its strong commitment to advancing pharmaceutical innovation and contributing to the state's economy, while actively supporting the broader U.S. healthcare system BRIDGEWATER, N.J., Oct. 28, 2025 /PRNewswire/ -- Global pharmaceutical leader, Lupin Limited (Lupin), commemorated the inauguration of its new corporate offices at 100 Somerset Corporate Blvd in Bridgewater, New Jersey. The new location expands Lupin's presence in the state, which already includes manufacturing and research facilities in Somerset. Governor Phil Murphy and Somerset County Commissioner Deputy Director Melonie Marano attended a ribbon-cutting ceremony at the offices, alongside Lupin executives, including Vinita Gupta, CEO, Spiro Gavaris, President, U.S. Generics and …

Lupin Logo (PRNewsfoto/Lupin Limited)

Total revenues of $276 million, up 18% year over year Annualized recurring revenue (ARR) 1  surpassed $1 billion milestone, ahead of March 2026 target Operating cash flow of $77 million, free cash flow2 of $74 million TINTON FALLS, N.J., Oct. 28, 2025 /PRNewswire/ -- Commvault (Nasdaq: CVLT) today announced its financial results for the fiscal second quarter ended September 30, 2025.

Commvault is a leading provider of cyber resilience and data protection solutions for hybrid cloud organizations. (PRNewsfoto/Commvault)

SUNRISE, Fla., Oct. 28, 2025 /PRNewswire/ -- A new white paper from MASA® reveals an often-overlooked but escalating crisis that threatens American workers and their employers: the fear of ambulance bills is causing employees to hesitate—or even refuse—to call 911 in medical emergencies. This hesitation is not just a personal risk; it's a systemic threat to workforce health, productivity, and the bottom line.

Founded in 1974, Medical Access & Service Advantage (MASA®) is a leading provider of emergency and medical transportation benefits. Designed to enhance primary healthcare plans, MASA supports members by covering additional out-of-pocket costs for medical transport while also offering other benefits for use during recovery and beyond. With services spanning all 50 states, Canada, and 14 international markets, MASA protects more than 2 million members. For more information, visit masaaccess.com. (PRNewsfoto/MASA Global)

Continued year-over-year sales growth driven by aerospace & defense Record aerospace & defense sales of $793 million, representing 70% of Q 3 2025 sales Strong margin performance in HPMC and AA&S segments

(PRNewsfoto/Allegheny Technologies)

Myrio Therapeutics, the University of Pennsylvania Perelman School of Medicine, and NYU Langone Health have entered a research collaboration to accelerate the development of next-generation T cell immunotherapies Partnership with T cell experts Daniel J Powell Jr., PhD, and Mark Yarmarkovich, PhD PHILADELPHIA, NEW YORK and MELBOURNE, Australia, Oct. 28, 2025 /PRNewswire/ -- Myrio Therapeutics today announced a collaborative research partnership with the University of Pennsylvania's Perelman School of Medicine and NYU Langone Health to accelerate the development of next generation solid tumor T cell immunotherapeutics.

(PRNewsfoto/Myrio Therapeutics)

MADISON, Wis., Oct. 28, 2025 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) will report financial results for the first quarter of fiscal year 2026, ended September 30, 2025, during a conference call hosted by company management at 1:30 p.m. PT/4:30 p.m. ET on November 5, 2025. The conference call dial-in numbers are 1-833-316-0563 (USA) or 1-412-317-5747 (international). In addition, a dial-up replay of the conference call will be available approximately one hour after the call's conclusion for one week. The replay number is 1-855-669-9658 (USA) or 1-412-317-0088 (international), conference ID: 7403898.

Accuray Incorporated (PRNewsFoto/Accuray Incorporated) (PRNewsFoto/Accuray Incorporated)

CHARLOTTE, N.C., Oct. 28, 2025 /PRNewswire/ -- Honeywell (NASDAQ: HON) today introduced a breakthrough technology that converts agricultural and forestry waste into ready-to-use renewable fuels for hard-to-abate sectors, such as the maritime industry. The technology produces lower-carbon marine fuel, gasoline and sustainable aviation fuel (SAF) from inexpensive and abundant biomass sources like wood chips and crop residues.

(PRNewsfoto/Honeywell)

Landmark procedures launch the ENDURE 1 clinical study evaluating Optilume's safety and feasibility as a new minimally invasive option for patients with benign ureteric strictures. PORTSMOUTH, N.H., Oct. 28, 2025 /PRNewswire/ -- Laborie Medical Technologies, a global leader in diagnostic and therapeutic devices, today announced the successful completion of the first procedures using the Optilume® Ureteric Drug-Coated Balloon (DCB) in the ENDURE 1 study. These groundbreaking procedures mark a major milestone in advancing treatment options for patients suffering from benign ureteric strictures.

CALGARY, AB, Oct. 28, 2025 /PRNewswire/ - Syantra, Inc., a precision biotechnology company revolutionizing early cancer detection, today announced a clinical research partnership with Breast Cancer Foundation NZ. The partnership is a critical step in expanding Syantra's pioneering cancer detection platform, Onco-ID™, and the first cancer detection test developed with the platform, Onco-ID Breast.

Syantra Logo (CNW Group/Syantra Inc.)

PASADENA, Calif., Oct. 28, 2025 /PRNewswire/ -- Pasadena Private Lending, Inc. ("PPL"), a leading provider of senior secured business loans to successful entrepreneurs nationwide, announced today that it has closed on a new $150 million credit facility with KeyBank, expandable to $300 million. This new facility grows PPL's overall capital base from $160 million to over $350 million, significantly enhancing the firm's ability to meet the increasing demand for its lending solutions.

Pasadena Private Financial Group (PRNewsfoto/Pasadena Private Financial Group)

Pelareorep plus atezolizumab achieves 30% ORR in second-line or later (≥2L) squamous cell anal carcinoma (SCAC) relative to 13.8% for the FDA-approved 2L treatment The median duration of response was 15.5 months compared to 9.5 months for the current standard of care Company expects to discuss single-arm accelerated approval study with FDA in Q1 2026

Oncolytics Biotech® Inc. Logo (PRNewsfoto/Oncolytics Biotech® Inc.)

Pet Lovers and Veterinary Professionals in NYC Unite to Address Animal Overpopulation and Affordability Crisis NEW YORK, Oct. 28, 2025 /PRNewswire/ -- This fall, pet lovers and veterinary professionals in NYC are coming together to address the overpopulation of animals in shelters and the lack of affordable options for spaying and neutering. As the cost of living and pet care rises, animal shelters across the country are at critical capacity dealing with an influx of surrendered pets, oftentimes due to the price tag associated with their care. An estimated 5.8 million animals filled up facilities last year, according to the nonprofit Shelter Animals Count's national database. The main reason for pet surrender? people just can't afford their care.

HENDERSON, Nev., Oct. 28, 2025 /PRNewswire/ -- The Association of Movement Disorder Advanced Practice Providers (AMDAPP) is working to increase awareness and understanding of the role of Advanced Practice Providers and Advanced Nurses within the movement disorder community. The organization aims to highlight the importance of these professionals on multidisciplinary teams.

AMDAPP Logo (PRNewsfoto/Association of Movement Disorder Advanced Practice Providers)